Resumen

FIGUEROA CALDERON, Isabel; SAAVEDRA MOREDO, Daymí; DE LA TORRES SIERES, Yudith  y  SANCHEZ LUEIRO, Mayra. Effectiveness of magnesium sulfate in pre-eclampsia treatment. Rev Cubana Obstet Ginecol [online]. 2012, vol.38, n.4, pp.458-466. ISSN 0138-600X.

Introduction: eclampsia is a disease of human pregnancy, responsible for a significant increase in the rates of maternal and perinatal morbidity and mortality. Objective: to study the effectiveness of the use of magnesium sulfate in the treatment of pre-eclampsia. Methods: an intervention and evaluation study in health services was conducted from June 1^st to December 31^st, 2011. 98 pregnant women admitted to the Perinatal Care unit were the universe and sample of this study. They had been classified as pre-eclamptic. Results: 68.36 % of these women were 20-34 years old, 75.51 % were nulliparous. 2.04 % had oligoanuria as response to the drug. 100 % of these patients used hypotensive drugs and hydralazine was mostly used (63.25 %). More than 50 % delivered at the end of pregnancy with healthy weight of the product. 76.50 % of births occurred by cesarean. The most common maternal complication was hypertension, and neonatal depression at birth was present in 7.14 %. Conclusions: magnesium sulfate treatment was effective because it was able to reduce the number of pregnant women with eclampsia, when using prophylactically.

Palabras clave : magnesium sulfate; eclampsia and pre-eclampsia.

        · resumen en Español     · texto en Español     · Español ( pdf )